PLANETS
27.9.2021 18:02:10 CEST | Business Wire | Press release
teamLab Planets TOKYO in Toyosu, Tokyo welcomes “Vegan Ramen UZU Tokyo ” from Kyoto; a new artwork space; and a flower shop where visitors can take home the orchids used in one of the museum’s artworks. “Vegan Ramen UZU Kyoto” opened in Kyoto in March of 2020, becoming hugely popular with hour-long wait times. At “Vegan Ramen UZU Tokyo,” vegan ramen can be enjoyed in the Reversible Rotation - Non-Objective Space or Table of Sky and Fire artwork spaces.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210927005038/en/
There will also be a new flower shop, “teamLab Flower Shop & Art,” where visitors can take home orchids used in the artwork Floating Flower Garden: Flowers and I are of the Same Root, the Garden and I are One , in which visitors become one with over 13,000 orchids. All of these facilities open on Friday, October 8 to the public, not just to teamLab Planets museumgoers.
Vegan Ramen UZU Tokyo
: https://vegan-uzu.com/pages/uzu-tokyo-en
teamLab Planets
Museum Details: planets.teamlab.art
teamLab Planets
Highlight Video: https://youtu.be/xofyyJYYWMY
[Vegan Ramen UZU]
At "Vegan Ramen UZU Kyoto,” which opened in March of 2020 in Gosho-Minami, Kyoto, teamLab was responsible for designing the space and other aspects of the restaurant, where guests can enjoy vegan food while surrounded by art.
“Vegan Ramen UZU Tokyo ,” which will open at teamLab Planets , will have vegan ramen available for takeout, as well as to enjoy at the newly-opened Reversible Rotation - Non-Objective Space and Table of Sky and Fire artwork spaces. Flower Vegan Ramen, Green Tea Vegan Ramen, and Vegan Ice Cream will also be available only at “Vegan Ramen UZU Tokyo.”
Official Website: https://vegan-uzu.com/
Media Coverage of “Vegan Ramen UZU Kyoto”
-
Time Out
“teamLab has designed a vegan ramen restaurant in Kyoto”
https://www.timeout.com/tokyo/news/teamlab-has-designed-a-vegan-ramen-restaurant-in-kyoto-012021
Vegan Ramen Menu
- Soy Sauce Vegan Ramen
- Miso Vegan Ramen (Spicy)
[Vegan Ramen UZU Tokyo Only Menu]
- Green Tea Vegan Ramen
- Flower Vegan Ramen (Cold)
[New Public Artworks]
Reversible Rotation - Non-Objective Space
teamLab, 2021, Digital Installation, Sound: Hideaki Takahashi
Artwork: https://planets.teamlab.art/tokyo/ew/reversiblerotation_nonobjective/
The artwork space is freed from the physical boundaries of the surfaces of tables or chairs.
The Spatial Calligraphy rotates in the artwork space, every aspect rotating in the same direction. But because of the special characteristics of Ultrasubjective Space, it can appear to be rotating clockwise or counterclockwise.
Spatial calligraphy is calligraphy drawn in space, a form of calligraphy that teamLab has been exploring since it was founded. The artwork reconstructs calligraphy in three dimensional space to express the depth, speed and power of the brush stroke, and that calligraphy is then flattened using the logical structure teamLab calls ultrasubjective space. The calligraphy shifts between two and three dimensions.
Table of Sky and Fir
e
teamLab Architects, 2021
Artwork: https://planets.teamlab.art/tokyo/ew/tableskyfire_planets/
This table reflects the sky and the Universe of Fire Particles Falling from the Sky. The table is connected to the artwork and to the sky.
Human beings need to be connected to the world to live. teamLab hopes that people will eat something on this table while thinking that to live and to eat is to stay connected to the world.
[teamLab Flower Shop & Art]
This is a flower shop where visitors can take home orchids used in the artwork Floating Flower Garden: Flowers and I are of the Same Root, the Garden and I are One (photo above), in which visitors become one with over 13,000 orchids.
Orchids live on even after the flowers have fallen, blooming again and again, sometimes for decades. In order for people to take home a part of the work, we sell tote bags containing a variety of orchids. Those who wish to purchase orchids separately may do so from a more limited selection of orchid species.
[teamLab Planets ]
teamLab Planets is a museum where you walk through water, and a garden where you become one with the flowers. There are four massive exhibition spaces and two gardens.
By immersing the entire body with other people in these massive body immersive artworks, the boundary between the body and the artwork dissolves, the boundaries between the self, others, and the world become continuous, and we explore a new relationship without boundaries between ourselves and the world.
Enter barefoot, immerse your body with others in the artwork spaces, and become one with the world.
[Summary]
Vegan Ramen UZU Tokyo
https://vegan-uzu.com/pages/uzu-tokyo-en
Open Hours:
October
Mondays - Fridays 11:00 - 19:00
Saturdays 10:30 - 20:00
Sundays 10:30 - 19:00
Closed: same as closed days for teamLab Planets
teamLab Flower Shop & Art
Open Hours:
October
Mondays - Fridays 11:00 - 19:00
Saturdays 10:00 - 20:00
Sundays 10:00 - 19:00
Closed: same as closed days for teamLab Planets
teamlab Planets TOKYO
https://planets.teamlab.art/tokyo/
#teamLabPlanets
Term:
July 7, 2018 - End of 2022
Venue:
teamLab Planets TOKYO (6 Chome-1-16 Toyosu, Koto City, Tokyo
)
Hours:
September: Mon - Fri 10:00 - 20:00 / Sat, Sun, Holidays 9:00-20:00
October: Mon - Fri 10:00 - 19:00 / Sat 9:00 - 20:00 / Sun 9:00 - 19:00
* Last entry 1 hour before closing
Closed:
October 5
Admission:
[Entrance Pass]
Adults (ages 18 and older): JPY 3,200
University / Trade School Students: JPY 2,500
Middle School / High School Students: JPY 2,000
Children (ages 4 - 12): JPY 300
Infants (ages 3 and younger): Free
Seniors (ages 65 and older): JPY 2,400
Visitors with Disabilities: JPY 1,600
teamLab Planets TOKYO
Ticket Store: https://teamlabplanets.dmm.com/en
* Admission and exhibition hours are subject to change. Please check the official website for the latest information.
* A separate admission fee is required for the newly-opened artwork space Reversible Rotation - Non-Objective Space
. This space is also open to visitors other than teamLab Planets
museumgoers.
Official Social Media Pages:
Instagram: https://www.instagram.com/teamlab.planets/
Facebook: https://www.facebook.com/TL.Planets/
Twitter: https://twitter.com/teamLabPlanets
Measures Against the Spread of COVID-19:
Infection prevention measures such as entry restrictions are being implemented. Please check the website for details.
https://teamlabplanets.dmm.com/en/covid-19
[Press Kit]
https://goo.gl/tQXMLm
[Media Inquiries]
https://goo.gl/forms/fqn8DmGV8WWIntP53
[PLANETS Co., Ltd.]
The managing entity for facilities operations at teamLab Planets TOKYO
Address: Tokyo Nihonbashi Tower 26F, 2-7-1 Nihonbashi, Chuo-ku, Tokyo
[About teamLab]
teamLab (f. 2001) is an international art collective, an interdisciplinary group of various specialists such as artists, programmers, engineers, CG animators, mathematicians and architects whose collaborative practice seeks to navigate the confluence of art, science, technology, and the natural world.
teamLab aims to explore the relationship between the self and the world and new perceptions through art. In order to understand the world around them, people separate it into independent entities with perceived boundaries between them. teamLab seeks to transcend these boundaries in our perception of the world, of the relationship between the self and the world, and of the continuity of time. Everything exists in a long, fragile yet miraculous, borderless continuity.
teamLab has been the subject of numerous exhibitions at venues worldwide, including New York, London, Paris, Singapore, Silicon Valley, Beijing, Taipei, and Melbourne among others. The permanent museums teamLab Borderless opened in Odaiba,Tokyo in June 2018, and teamLab Borderless Shanghai in Huangpu District, Shanghai in November 2019. teamLab Planets , a museum where you walk through water and a garden where you become one with the flowers in Toyosu, Tokyo is on view until the end of 2022. The large-scale permanent exhibition teamLab SuperNature soft opened in Macao in June, 2020. teamLab’s annual life-work exhibition, VOLVO teamLab: A Forest Where Gods Live , is on view in Mifuneyama Rakuen, Takeo Hot Springs, Kyushu until November 7, 2021.
teamLab’s works are in the permanent collection of the Museum of Contemporary Art, Los Angeles; Art Gallery of New South Wales, Sydney; Art Gallery of South Australia, Adelaide; Asian Art Museum, San Francisco; Asia Society Museum, New York; Borusan Contemporary Art Collection, Istanbul; National Gallery of Victoria, Melbourne; and Amos Rex, Helsinki.
teamLab is represented by Pace Gallery , Martin Browne Contemporary , and Ikkan Art .
teamLab: https://www.teamlab.art/
Instagram: https://instagram.com/teamlab/
Facebook: https://www.facebook.com/teamLab.inc
Twitter: https://twitter.com/teamLab_net
YouTube: https://www.youtube.com/c/teamLabART
View source version on businesswire.com: https://www.businesswire.com/news/home/20210927005038/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
